$5.05
OUTLOOK THERAPEUTICS is a biotechnology business based in the US. OUTLOOK THERAPEUTICS shares (OTLK) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.19 – an increase of 4.85% over the previous week. OUTLOOK THERAPEUTICS employs 24 staff and has a trailing 12-month revenue of around $5.9 million.
What's in this guide?
Our top picks for where to buy OUTLOOK THERAPEUTICS stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy OUTLOOK THERAPEUTICS stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – OTLK. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy OUTLOOK THERAPEUTICS stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
OUTLOOK THERAPEUTICS stock price (NASDAQ: OTLK)
Use our graph to track the performance of OTLK stocks over time.OUTLOOK THERAPEUTICS shares at a glance
Latest market close | $5.19 |
---|---|
52-week range | $4.61 - $18.00 |
50-day moving average | $6.52 |
200-day moving average | $7.66 |
Wall St. target price | $37.20 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-5.89 |
Is it a good time to buy OUTLOOK THERAPEUTICS stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
OUTLOOK THERAPEUTICS price performance over time
Historical closes compared with the close of $5.09 from 2024-10-14
1 week (2024-10-10) | 3.04% |
---|---|
1 month (2024-09-17) | -15.73% |
3 months (2024-07-17) | -43.13% |
6 months (2024-04-17) | -40.88% |
1 year (2023-10-17) | 1,182.44% |
---|---|
2 years (2022-10-17) | 317.21% |
3 years (2021-10-15) | 141.23% |
5 years (2019-10-17) | 291.54% |
OUTLOOK THERAPEUTICS financials
Revenue TTM | $5.9 million |
---|---|
Gross profit TTM | $-42,330,856 |
Return on assets TTM | -83.69% |
Return on equity TTM | -3.65% |
Profit margin | 0% |
Book value | $-3.58 |
Market Capitalization | $121.1 million |
TTM: trailing 12 months
OUTLOOK THERAPEUTICS share dividends
We're not expecting OUTLOOK THERAPEUTICS to pay a dividend over the next 12 months.
Have OUTLOOK THERAPEUTICS's shares ever split?
OUTLOOK THERAPEUTICS's shares were split on a 1:20 basis on 13 March 2024. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OUTLOOK THERAPEUTICS shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for OUTLOOK THERAPEUTICS shares which in turn could have impacted OUTLOOK THERAPEUTICS's share price.
OUTLOOK THERAPEUTICS share price volatility
Over the last 12 months, OUTLOOK THERAPEUTICS's shares have ranged in value from as little as $4.61 up to $18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OUTLOOK THERAPEUTICS's is 0.63. This would suggest that OUTLOOK THERAPEUTICS's shares are less volatile than average (for this exchange).
OUTLOOK THERAPEUTICS overview
Outlook Therapeutics, Inc. , operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with BioLexis Pte. Ltd. and Zhejiang Huahai Pharmaceutical Co.
Frequently asked questions
What percentage of OUTLOOK THERAPEUTICS is owned by insiders or institutions?Currently 35.582% of OUTLOOK THERAPEUTICS shares are held by insiders and 35.955% by institutions. How many people work for OUTLOOK THERAPEUTICS?
Latest data suggests 24 work at OUTLOOK THERAPEUTICS. When does the fiscal year end for OUTLOOK THERAPEUTICS?
OUTLOOK THERAPEUTICS's fiscal year ends in September. Where is OUTLOOK THERAPEUTICS based?
OUTLOOK THERAPEUTICS's address is: Building F, Iselin, NJ, United States, 08852 What is OUTLOOK THERAPEUTICS's ISIN number?
OUTLOOK THERAPEUTICS's international securities identification number is: US69012T2069 What is OUTLOOK THERAPEUTICS's CUSIP number?
OUTLOOK THERAPEUTICS's Committee on Uniform Securities Identification Procedures number is: 68235M204
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question